Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional SurgeryAlessandro Brunelli, Doreen Addrizzo‐Harris, Anthony W. Kim et al.|CHEST Journal|2013Cited by 901
Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyPaul Harmatz, Stuart J. Swiedler, Zi‐Fan Yu et al.|The Journal of Pediatrics|2006Cited by 364
Respiratory and sleep disorders in mucopolysaccharidosisKenneth I. Berger, David M. Rapoport, Simone Chaves Fagondes et al.|Journal of Inherited Metabolic Disease|2012Cited by 158
Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidanceMehmet Umut Akyol, Maurizio Scarpa, Tord D. Alden et al.|Orphanet Journal of Rare Diseases|2019Cited by 114
Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathyManisha Kak Korb, Kendrea L. Garand, Allison Peck et al.|Orphanet Journal of Rare Diseases|2022Cited by 36